Alkermes (ALKS) News Today $27.88 -0.16 (-0.57%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 27 at 12:30 AM | markets.businessinsider.comStrong Buy on Alkermes: Solid Q2 Earnings and Promising Drug Pipeline Drive Positive OutlookJuly 26 at 7:29 PM | markets.businessinsider.comMaintaining Hold on Alkermes: Weighing Solid Performance Against Seasonal Slowdown and Pipeline UncertaintiesJuly 26 at 8:10 AM | americanbankingnews.comAlkermes (NASDAQ:ALKS) Given New $38.00 Price Target at Robert W. BairdJuly 26 at 7:06 AM | americanbankingnews.comAlkermes (NASDAQ:ALKS) Shares Gap Up to $25.00July 25 at 2:07 PM | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Alkermes (ALKS) and Viking Therapeutics (VKTX)July 25 at 11:09 AM | marketbeat.comAlkermes (NASDAQ:ALKS) Earns Overweight Rating from Cantor FitzgeraldCantor Fitzgerald reissued an "overweight" rating and set a $48.00 price target on shares of Alkermes in a research note on Thursday.July 25 at 10:33 AM | marketbeat.comAlkermes (NASDAQ:ALKS) Price Target Raised to $32.00 at JPMorgan Chase & Co.JPMorgan Chase & Co. boosted their target price on shares of Alkermes from $31.00 to $32.00 and gave the stock a "neutral" rating in a research note on Thursday.July 25 at 9:04 AM | markets.businessinsider.comStrong Performance and Clinical Promise Uphold Buy Rating for Alkermes with $32 Target PriceJuly 25 at 9:04 AM | msn.comAlkermes plc (NASDAQ:ALKS) Q2 2024 Earnings Call TranscriptJuly 25 at 9:00 AM | americanbankingnews.comAlkermes (NASDAQ:ALKS) Price Target Raised to $37.00July 24 at 6:51 PM | finance.yahoo.comIs Alkermes plc's (NASDAQ:ALKS) Latest Stock Performance Being Led By Its Strong Fundamentals?July 24 at 6:51 PM | markets.businessinsider.comAlkermes Lags Q2 Earnings EstimatesJuly 24 at 10:31 AM | marketbeat.comAlkermes (NASDAQ:ALKS) Releases FY 2024 Earnings GuidanceAlkermes (NASDAQ:ALKS) updated its FY 2024 earnings guidance. The company provided EPS guidance of 2.800-2.800 for the period, compared to the consensus estimate of 2.670. The company also issued revenue guidance of $1.5 billionillion-$1.6 billionillion, compared to the consensus estimate of $1.5 billionillion.July 24 at 7:59 AM | seekingalpha.comAlkermes plc 2024 Q2 - Results - Earnings Call PresentationJuly 24 at 7:00 AM | prnewswire.comAlkermes plc Reports Second Quarter 2024 Financial ResultsJuly 23 at 11:29 PM | markets.businessinsider.comAlkermes earnings: here's what Wall Street expectsJuly 23 at 7:46 AM | americanbankingnews.comAlkermes (ALKS) to Release Quarterly Earnings on WednesdayJuly 22, 2024 | marketbeat.comEdgestream Partners L.P. Has $2.16 Million Position in Alkermes plc (NASDAQ:ALKS)Edgestream Partners L.P. grew its holdings in Alkermes plc (NASDAQ:ALKS - Free Report) by 206.1% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 79,609 shares of the company's stock after purchasingJuly 21, 2024 | marketbeat.comAlkermes plc (NASDAQ:ALKS) Shares Sold by Westfield Capital Management Co. LPWestfield Capital Management Co. LP lessened its stake in Alkermes plc (NASDAQ:ALKS - Free Report) by 21.1% during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,282,741 shares of the company's stock after selling 343,042July 20, 2024 | americanbankingnews.comAlkermes (NASDAQ:ALKS) Downgraded to Hold at StockNews.comJuly 20, 2024 | marketbeat.comAlkermes (NASDAQ:ALKS) Stock Rating Lowered by StockNews.comStockNews.com downgraded shares of Alkermes from a "buy" rating to a "hold" rating in a research report on Saturday.July 18, 2024 | marketbeat.comFoundry Partners LLC Takes $3.86 Million Position in Alkermes plc (NASDAQ:ALKS)Foundry Partners LLC purchased a new stake in shares of Alkermes plc (NASDAQ:ALKS - Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 142,471 shares of the company's stock, valued at approximatelJuly 18, 2024 | marketbeat.comAlkermes (ALKS) to Release Earnings on WednesdayAlkermes (NASDAQ:ALKS) will be releasing earnings before the market opens on Wednesday, July 24, Zacks reports.July 17, 2024 | prnewswire.comAlkermes to Report Second Quarter Financial Results on July 24, 2024July 17, 2024 | americanbankingnews.comBrokerages Set Alkermes plc (NASDAQ:ALKS) PT at $36.50July 16, 2024 | americanbankingnews.comAlkermes plc (NASDAQ:ALKS) Short Interest UpdateJuly 15, 2024 | marketbeat.comSusquehanna Portfolio Strategies LLC Reduces Position in Alkermes plc (NASDAQ:ALKS)Susquehanna Portfolio Strategies LLC lowered its holdings in Alkermes plc (NASDAQ:ALKS - Free Report) by 50.7% in the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 125,876 shares of the company's stock after selling 129,271 shares during the period. SusqueJuly 15, 2024 | marketbeat.comAlkermes plc (NASDAQ:ALKS) Sees Large Increase in Short InterestAlkermes plc (NASDAQ:ALKS - Get Free Report) saw a significant growth in short interest in June. As of June 30th, there was short interest totalling 13,680,000 shares, a growth of 14.4% from the June 15th total of 11,960,000 shares. Based on an average daily trading volume, of 1,840,000 shares, the short-interest ratio is presently 7.4 days.July 14, 2024 | marketbeat.comSusquehanna Fundamental Investments LLC Buys Shares of 86,440 Alkermes plc (NASDAQ:ALKS)Susquehanna Fundamental Investments LLC purchased a new position in shares of Alkermes plc (NASDAQ:ALKS - Free Report) in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 86,440 shares of the company's stock, valued at appJuly 14, 2024 | marketbeat.comAlkermes plc (NASDAQ:ALKS) Given Consensus Rating of "Moderate Buy" by BrokeragesShares of Alkermes plc (NASDAQ:ALKS - Get Free Report) have been given an average rating of "Moderate Buy" by the eleven brokerages that are currently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, three have given a hold rating andJuly 13, 2024 | marketbeat.comDuality Advisers LP Makes New Investment in Alkermes plc (NASDAQ:ALKS)Duality Advisers LP acquired a new stake in shares of Alkermes plc (NASDAQ:ALKS - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 70,389 shares of the company's stock, valJuly 12, 2024 | marketbeat.comFY2024 EPS Estimates for Alkermes plc Lowered by Leerink Partnrs (NASDAQ:ALKS)Alkermes plc (NASDAQ:ALKS - Free Report) - Stock analysts at Leerink Partnrs decreased their FY2024 earnings per share estimates for shares of Alkermes in a research note issued to investors on Tuesday, July 9th. Leerink Partnrs analyst M. Goodman now expects that the company will post earnings pJuly 10, 2024 | marketbeat.comAlkermes (NASDAQ:ALKS) Trading Down 2%Alkermes (NASDAQ:ALKS) Stock Price Down 2%July 7, 2024 | marketbeat.comCapstone Investment Advisors LLC Invests $883,000 in Alkermes plc (NASDAQ:ALKS)Capstone Investment Advisors LLC purchased a new stake in shares of Alkermes plc (NASDAQ:ALKS - Free Report) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 32,630 shares of the company's stock, valueJuly 2, 2024 | marketbeat.comAlkermes plc (NASDAQ:ALKS) Shares Sold by Allspring Global Investments Holdings LLCAllspring Global Investments Holdings LLC lowered its position in shares of Alkermes plc (NASDAQ:ALKS - Free Report) by 68.0% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 120,701 shares of the companJune 27, 2024 | marketbeat.comQ4 2025 EPS Estimates for Alkermes plc Increased by Zacks Research (NASDAQ:ALKS)Alkermes plc (NASDAQ:ALKS - Free Report) - Zacks Research upped their Q4 2025 earnings estimates for Alkermes in a note issued to investors on Tuesday, June 25th. Zacks Research analyst R. Department now anticipates that the company will post earnings of $0.57 per share for the quarter, up from tJune 25, 2024 | marketbeat.comAlkermes plc (NASDAQ:ALKS) Shares Acquired by Vanguard Group Inc.Vanguard Group Inc. increased its position in shares of Alkermes plc (NASDAQ:ALKS - Free Report) by 12.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 20,955,454 shares of the company's stock after purchasing an adJune 22, 2024 | marketbeat.comAlkermes plc (NASDAQ:ALKS) Shares Sold by Goldman Sachs Group Inc.Goldman Sachs Group Inc. cut its position in shares of Alkermes plc (NASDAQ:ALKS - Free Report) by 27.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,402,819 shares of the company's stock after selling 523,805 sharesJune 21, 2024 | marketbeat.comLos Angeles Capital Management LLC Acquires 122,980 Shares of Alkermes plc (NASDAQ:ALKS)Los Angeles Capital Management LLC grew its holdings in shares of Alkermes plc (NASDAQ:ALKS - Free Report) by 525.5% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 146,381 shares of the company's stock after buying an additional 122June 18, 2024 | marketbeat.comAlkermes plc (NASDAQ:ALKS) Shares Bought by Teachers Retirement System of The State of KentuckyTeachers Retirement System of The State of Kentucky boosted its holdings in shares of Alkermes plc (NASDAQ:ALKS - Free Report) by 34.9% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 175,June 17, 2024 | marketbeat.comWellington Management Group LLP Purchases 3,494,678 Shares of Alkermes plc (NASDAQ:ALKS)Wellington Management Group LLP grew its position in shares of Alkermes plc (NASDAQ:ALKS - Free Report) by 29.8% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 15,241,470 shares of the company's stock after purchasing an additional 3,494,678June 10, 2024 | marketbeat.comNeuberger Berman Group LLC Purchases 58,399 Shares of Alkermes plc (NASDAQ:ALKS)Neuberger Berman Group LLC increased its position in shares of Alkermes plc (NASDAQ:ALKS - Free Report) by 29.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 259,238 shares of the company's stock afterJune 8, 2024 | marketbeat.comAlkermes plc (NASDAQ:ALKS) Stock Holdings Decreased by Sectoral Asset Management Inc.Sectoral Asset Management Inc. reduced its position in Alkermes plc (NASDAQ:ALKS - Free Report) by 93.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 15,330 shares of the company'sJune 7, 2024 | marketbeat.comAlkermes plc (NASDAQ:ALKS) Shares Purchased by RTW Investments LPRTW Investments LP increased its position in shares of Alkermes plc (NASDAQ:ALKS - Free Report) by 338.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,901,523 shares of the company's stock after acquiring an additional 3,012,4June 5, 2024 | marketbeat.comAlkermes plc (NASDAQ:ALKS) Stock Position Lowered by Armistice Capital LLCArmistice Capital LLC lessened its position in Alkermes plc (NASDAQ:ALKS - Free Report) by 36.7% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,200,000 shares of the company's stock after selling 696,775 shares during the quaJune 4, 2024 | marketbeat.comCampbell & CO Investment Adviser LLC Takes $2.31 Million Position in Alkermes plc (NASDAQ:ALKS)Campbell & CO Investment Adviser LLC bought a new position in Alkermes plc (NASDAQ:ALKS - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 83,170 shares of the company's stock, valued at approximately $2,307,June 3, 2024 | prnewswire.comAlkermes Presents Data From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 1 at SLEEP 2024June 2, 2024 | marketbeat.comEagle Asset Management Inc. Has $16.52 Million Stock Position in Alkermes plc (NASDAQ:ALKS)Eagle Asset Management Inc. lowered its holdings in shares of Alkermes plc (NASDAQ:ALKS - Free Report) by 31.4% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 595,597 shares of the company's stock after selling 272,276 shares during thMay 31, 2024 | marketbeat.comJanney Montgomery Scott LLC Invests $927,000 in Alkermes plc (NASDAQ:ALKS)Janney Montgomery Scott LLC bought a new position in Alkermes plc (NASDAQ:ALKS - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 33,410 shares of the company's stock, valuedMay 29, 2024 | prnewswire.comAlkermes to Participate in Two Upcoming Investor Conferences Get Alkermes News Delivered to You Automatically Sign up to receive the latest news and ratings for ALKS and its competitors with MarketBeat's FREE daily newsletter. Email Address 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here ALKS Media Mentions By Week ALKS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALKS News Sentiment▼0.390.61▲Average Medical News Sentiment ALKS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALKS Articles This Week▼276▲ALKS Articles Average Week Get Alkermes News Delivered to You Automatically Sign up to receive the latest news and ratings for ALKS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Agios Pharmaceuticals News Pacira BioSciences News Atea Pharmaceuticals News ADC Therapeutics News Nektar Therapeutics News Seres Therapeutics News Karuna Therapeutics News BioMarin Pharmaceutical News Incyte News Neurocrine Biosciences News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALKS) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alkermes plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Alkermes With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.